Khadim India Approves Allotment of 10.23 Lakh Convertible Warrants at ₹110 Each
Khadim India Ltd · Others (Uncategorized) · 26 Sept 2026, 2:37 am
Khadim India Approves Allotment of 10.23 Lakh Convertible Warrants at ₹110 Each Khadim India Limited's Board approved the preferential allotment of 10,22,727 fully convertible equity share warrants on 25th Sep'26 at ₹110 per warrant, aggregating ₹11.25 crore. The company received an upfront payment of 25% of the issue price, with the remaining 75% payable upon conversion within 18 months. Promoter Siddhartha Roy Burman was allotted 2,27,273 warrants (increasing shareholding to 9.59% upon full conversion), while 7,95,454 warrants were allocated across 10 non-promoter/public investors. Unexercised warrants after 18 months will lapse and face forfeiture.
Original exchange filing (PDF)
More announcements from Khadim India Ltd
- investor Presentation on the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2026 · 16 Nov 2026
- Resignation of Mr. Abhijit Dan from the position of Group Company Secretary & Head-Legal (also "Key Managerial Personnel" and "Compliance Officer") of the Company with effect from November .... · 06 Nov 2026
- Unaudited Financial Results for the quarter and half year ended September 30, 2026 · 05 Nov 2026
- Khadim India Limited has informed the Exchange regarding Outcome of Board Meeting held on November 05, 2026. · 05 Nov 2026
- Khadim India Limited has submitted to the Exchange, the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2026 · 05 Nov 2026
- Outcome of Board Meeting held on November 05, 2026 · 05 Nov 2026
- Khadim India Limited has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . · 05 Nov 2026
- Khadim India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve Unaudited Standalone and Consolidated .... · 05 Nov 2026
